A study by researchers at FAU and collaborators finds anti-adhesion drugs derived from cone snail venom may hold the key to treating malaria, COVID-19, AIDS and other diseases using blockage therapies.
FAU has launched a registry and repository to contribute to new discoveries and knowledge related COVID-19 and is currently enrolling participants with prior documented positive test reports.
Researchers from the Schmidt College of Medicine have developed a simplified COVID-19 testing protocol that is rapid, reliable and offers distinct advantages with less labor, expertise and equipment needed.
Lawrence Toll, Ph.D., has been named by The Web of Science(TM) among its most Highly Cited Researchers(TM). His publications rank in the top 1 percent by citations according to Clarivate(TM).
FAU and Memorial Healthcare System have formed a research partnership, which combines their expertise and resources in clinical research, clinical trials, basic research and translational biomedical research.
A study by FAU neuroscientists demonstrates how 'coming home' produces a signal of comfort in mice and is the first to show that home evokes a surge of dopamine that mimics the response to a dose of cocaine.
FAU Schmidt College of Medicine researcher has developed a novel device to conveniently sanitize contaminated masks and other items at home or at work and has received a provisional patent for the technology.
FAU Schmidt College of Medicine researchers reviewed the most reliable data from remdesivir randomized trials. In a commentary, they conclude that effective public health strategies are more urgently needed.
A retrospective cross-sectional study by FAU Schmidt College of Medicine researchers and collaborators, shows that information in electronic health records may help identify patients with opioid use disorder.
FAU Schmidt College of Medicine researchers will analyze stem cell activation with a focus on age-related and degenerative diseases to provide a basis for the development of regenerative therapies.